Anti-FGFR1 antibody [EPR806Y] ab76464 from Abcam

Product Specs
ItemAnti-FGFR1 antibody [EPR806Y]
CompanyAbcam
Price Supplier Page View Company Product Page
Catalog Numberab76464
Antibody TypePrimary
HostRabbit
Quantity10 UL, 40 UL, 100 UL
ClonalityMonoclonal
CloneEPR806Y
ApplicationsImmunocytochemistry/ Immunofluorescence, Immunoprecipitation, Western blot, Immunocytochemistry/ Immunofluorescence, Immunoprecipitation, Western blot, Immunocytochemistry/ Immunofluorescence, Immunoprecipitation, Western blot
Conjugate/TagUnconjugated
IsotypeIgG
Research AreaNeuroscience
Gene NameFGFR1
ValidationKnockOut Validated
ReactivityHuman
TargetFGFR1

Add to Compare List

Abcam

Discovery Drive

Cambridge Biomedical Campus

Cambridge CB2 0AX

United Kingdom

Phone: +44 (0) 1223 696000 (option 1)
+44 (0) 1223 696000 (option 2)
+44 (0) 1223 771600

Company Profile

Website: http://www.abcam.com

(1) Circular RNA encoded MET variant promotes glioblastoma tumorigenesisNature communicationsJuly 25, 2023Zhong J, Wu X, Gao Y, Chen J, Zhang M, Zhou H, Yang J, Xiao F, Yang X, Huang N, et al.1:1000), anti-phospho PDGFR alpha Y720 (Abcam, ab134068, clone EP2478, 1:1000), anti-FGFR1 (Abcam, ab76464, clone EPR806Y, 1:500), anti-phospho FGFR1 Y654 (Abcam, ab59194, 1:1000), anti-panTrk (Abcam, ab76291,

(2) LBP1C-2 from Lycium barbarum maintains skeletal muscle satellite cell pool by interaction with FGFR1iScienceMay 19, 2023Meng J, Lv Z, Chen X, Sun C, Jin C, Ding K, Chen C.Anti-FGFR1 (phospho Y653) antibody [EPR843(N)],Abcam,Cat# ab111124; RRID: AB_10859625 Anti-FGFR1 antibody [EPR806Y],Abcam,Cat#ab76464; RRID: AB_1523613 Phospho-p38 MAPK (Thr180/Tyr182) (D3F9) Rabbit mAb,Cell signaling technology,Cat#4511;

(3) LHX2 facilitates the progression of nasopharyngeal carcinoma via activation of the FGF1/FGFR axisBritish journal of cancerOctober 1, 2022Xie T, Du K, Liu W, Liu C, Wang B, Tian Y, Li R, Huang X, Lin J, Jian H, et al.Proteintech Group. Antibodies against LHX2 (ab243030), Vimentin (ab8978), FGF1 (ab179455), ZEB1 (ab203829), FGFR1 (ab76464), FGFR2 (ab109372), FRS (ab183492) and TWIST1 (ab50581) were purchased from Abcam. Antibodies against

(4) Long noncoding RNA CCDC183-AS1 depletion represses breast cancer cell proliferation, colony formation, and motility by sponging microRNA-3918Oncology ResearchAugust 1, 2022TAO LIU, LIMIN ZHOU, LIANBO ZHANG, XIN GUAN, Y I DONGthe nonspecific binding sites. The membranes were then added with primary antibodies targeting FGFR1 (ab76464) or GAPDH (ab181602; Abcam, Cambridge, UK) and cultivated at 4°C for 12 h, followed by extensive washing

(5) Circular RNA hsa_circ_0011298 enhances Taxol resistance of non‐small cell lung cancer by regulating miR‐486‐3p/CRABP2 axisJournal of Clinical Laboratory AnalysisMay 1, 2022Yihong Wu, Jieyun Xie, Han Wang, Shufang Hou, Jiuhuan Fengantibodies: KI67 (ab181255; 1:5000; Abcam), Bax (ab32503; 1:3000; Abcam), multidrug resistance protein (MRP1; ab76464; 1:1000; Abcam), CRABP2 (ab181255; 1:3000; Abcam), and β‐actin (ab8226; 1:1000; Abcam), and then secondary

(6) Aging affects the biological activity of fibroblast growth factor (FGF) in gastric epithelial cell, which is partially rescued by uridineBioengineeredFebruary 2, 2022Xiaomei Zhang, Huifeng Zhang, Jingli Gong, Huan Yu, Di Wu, Junyu Hou, Minghui Li, Xin Sun(Shanghai, China). MTT kit was obtained form Beyotime Biotechnology Co., Ltd (Shanghai, China). Anti-FGFR (#ab76464 at 1/100 dilution), anti-STAT3 (#ab68153 at 1/200 dilution) and aniti-STAT5 (#ab230670 at 1/500 dilution)

(7) An EMT-primary cilium-GLIS2 signaling axis regulates mammogenesis and claudin-low breast tumorigenesisScience advancesOctober 29, 2021Wilson MM, Callens C, Le Gallo M, Mironov S, Ding Q, Salamagnon A, Chavarria TE, Viel R, Peasah AD, Bhutkar A, et al.KIF3A (1:1000; ProteinTech 13930-1- AP), IFT20 (1:100; ProteinTech 13615-1-AP), FGFR1 (1:1000; Abcam ab76464), pFGFR1 (1:500; Cell Signaling 3471), BBS11 (1:1000; ProteinTech 10326-1-AP), HA (1:1000; Roche 11867423001),

(8) Fibroblast Growth Factor 2 Conjugated with Monomethyl Auristatin E Inhibits Tumor Growth in a Mouse ModelBiomacromoleculesOctober 11, 2021Mateusz A. Krzyscik, Malgorzata Zakrzewska, Vigdis Sørensen, Geir Frode Øy, Skjalg Brunheim, Ellen M. Haugsten, Gunhild M. Mælandsmo, Antoni Wiedlocha, Jacek OtlewskiMO), goat anti-FGF2 antibody (sc1390) from Santa Cruz Biotechnology (Dallas, TX), rabbit anti-FGFR1(ab76464) from Abcam (UK), mouse anti-EEA1 (early endosomal antigen protein-1, #610456) from BD Transduction

(9) Dual inhibition of FGFR4 and BCL-xL inhibits multi-resistant ovarian cancer with BCL2L1 gainAging (Albany NY)August 15, 2021Ting Guo, Chao Gu, Bin Li, Congjian Xuantibodies against BCL2L2 (BCL-w) (ab190952; 1:200; Abcam), BCL2L1 (BCL-xL) (ab270253; 1:200; Abcam), FGFRs (ab76464 for FGFR1 at 1:500; ab109372 for FGFR2 at 1:500; ab133644 for FGFR3 at 1:500; ab178396 for FGFR4 at

(10) LncRNA PVT1 Facilitates Proliferation, Migration and Invasion of NSCLC Cells via miR-551b/FGFR1 AxisOncoTargets and TherapyJune 2, 2021Xi Wang et al.milk at room temperature for 1 h. Then the primary antibody (rabbit anti-FGFR1 monoclonal antibody, ab76464, Abcam, Shanghai, China, 1:1000) was used to incubate the PVDF membrane at 4°C overnight and then rinsed

(11) Long non-coding RNA CERS6-AS1 facilitates the oncogenicity of pancreatic ductal adenocarcinoma by regulating the microRNA-15a-5p/FGFR1 axisAging (Albany NY)February 28, 2021Zhennan Yun, Fanqi Meng, Shiquan Li, Ping Zhangtemperature using 5% nonfat milk. Subsequently, the membranes were probed overnight with anti-FGFR1 (ab76464; Abcam, Cambridge, UK) and anti-GAPDH (ab128915; Abcam) primary antibodies at 4° C, rinsed with TBST

(12) A pentapeptide enabled AL3810 liposome-based glioma-targeted therapy with immune opsonic effect attenuatedActa Pharmaceutica Sinica BJanuary 1, 2021Jinyang Li et al.anti-CD31 antibody (ab28364), rabbit anti-VEGF receptor 1 antibody (ab2350), rabbit anti-FGFR1 antibody (ab76464), goat anti-rabbit IgG H&L (Alexa Fluor® 488, ab150077) and rabbit anti-C3 antibody (ab200999) were

(13) Actomyosin and the MRTF-SRF pathway downregulate FGFR1 in mesenchymal stromal cellsCommunications BiologyDecember 1, 2020Jip Zonderland, Silvia Rezzola, Lorenzo Moronitheir respective blocking buffer overnight at 4 °C. All antibodies were ordered from Abcam: FGFR1: ab76464 1/500; Paxillin: ab32084 1/1000; Zyxin: ab58210 1/1000; YAP1: ab52771 1/1000; SRF: ab53147 1/250; and

(14) Hsa_circRNA _0000518 facilitates breast cancer development via regulation of the miR ‐326/ FGFR1 axisThoracic CancerNovember 1, 2020Jing Jiang, Hui Lin, Shenghong Shi, Ying Hong, Xianan Bai, Xuchen Caowith 5% skim milk. The membranes were then incubated with primary antibodies, including anti‐FGFR1 (ab76464, 1:500, Abcam) and anti‐GAPDH (ab9484, 1:1000, Abcam). GAPDH was deemed as a loading control. Next,

(15) Nintedanib inhibits keloid fibroblast functions by blocking the phosphorylation of multiple kinases and enhancing receptor internalizationActa Pharmacologica SinicaSeptember 1, 2020Bo-ya Zhou, Wen-bo Wang, Xiao-li Wu, Wen-jie Zhang, Guang-dong Zhou, Zhen Gao, Wei Liuab39638,Rabbit-anti-human,WB VEGF Receptor 3,Abcam ab27278,Rabbit-anti-human,WB FGF Receptor 1,Abcam ab76464,Rabbit-anti-human,WB FGF Receptor 2,Abcam ab109372,Rabbit-anti-human,WB FGF Receptor 3,Abcam ab133644,Rabbit-anti-human,WB PDGF

(16) Circ_0015756 Aggravates Hepatocellular Carcinoma Development by Regulating FGFR1 via Sponging miR-610Cancer Management and ResearchAugust 18, 2020Weisheng Guo, Lin Zhao, Guangya Wei, Peng Liu, Yu Zhang, Liran Fuμg) of protein was used in the Western blot analysis. The primary antibodies used were anti-FGFR1 (ab76464; Abcam, Cambridge, MA. USA) and GAPDH (ab9485; Abcam). The secondary antibody used was anti-Goat anti-Rabbit

(17) miR‑802 inhibits the aggressive behaviors of non‑small cell lung cancer cells by directly targeting FGFR1International journal of oncologyJune 1, 2019Zhang J, Li J, Li S, Zhou C, Qin Y, Li X.antibodies used in this study were as follows: rabbit anti‑human monoclonal FGFR1 antibody (cat. no. ab76464; 1:1,000 dilution; Abcam), mouse anti‑human monoclonal phosphoinositide 3‑kinase (PI3K; cat. no. ab189403;

(18) FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndromeLeukemiaNovember 1, 2018Tianxiang Hu, Qing Wu, Yating Chong, Haiyan Qin, Candace J. Poole, Jan van Riggelen, Mingqiang Ren, John K. Cowell(Cell signaling, Inc) was raised against a recombinant protein specific to the FGFR1 carboxy terminus, ab76464 (Abcam) was raised against a synthetic peptide corresponding to aa 800 to the C-terminus and ab58516

(19) Genomic profiling of ER⁺breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistanceScience Translational MedicineAugust 9, 2017Jennifer M. Giltnane et al.using primary antibodies against the following targets: Actin (Cell Signaling, #4970), FGFR1 (Abcam, ab76464), Cyclin D1 (Santa Cruz, sc-718), ERα (Santa Cruz, sc-8002), FLAG (Sigma, F3165), pERK1/2 (T202/Y204,

(20) E-Cadherin and FGFR1 Expression in Mouse Osteoblastogenesis in Normoxic CulturesInt J Biomed SciMay 24, 2017Osama Al-Amersamples were separated on 12.5% SDS-PAGE, blotted on PVDF membranes and probed with anti-FGFR1 antibody ab76464 (Abcam, UK) at 1:1000 dilution, anti-E-cadherin antibody ab15148 (Abcam, UK) 1:1000 dilution or with

Be the First to Write a Review!

Anti-FGFR1 antibody [EPR806Y] from Abcam

Abcam

Citations (29)

Reviews

Anti-FGFR1 antibody [EPR806Y] from Abcam

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map